# Bumame

**Canonical:** https://apis.io/providers/bumame/  
**Website:** https://bumame.com  
**APIs profiled:** 0

Bumame is an Indonesian healthcare provider ("Elevating Indonesian Healthcare") delivering global-standard health screening and preventive-care services to Indonesian families. It operates a network of clinics and offers medical check-up packages, laboratory testing, vaccination and boosters, maternal and child health services, early cancer screening and genetic DNA testing, vitamin infusions, home care, doctor consultations, and corporate health programs, with online appointment booking. Backed by 500 Global. Surfaced as a portfolio-company lead in the API Evangelist network; no public developer API surface has been found to date.

## Kin Score — 10.5 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 10.5).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 7.1 |
| Commercial Clarity | 21.1 |
| Access Clarity | 21.1 |

Regulatory layer — **Health**: 17.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Bumame Domain Security** — TLSv1.3 · DMARC

## Tags

Company, Healthcare, Health Screening, Laboratory, Diagnostics, Preventive Care, Telehealth, Indonesia

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/bumame/). Scores are computed from the provider's own public artifacts under a published rubric.
